Akshay Vaishnaw - Insider Trading Tracker

Editas Medicine, Inc.

US ˙ NasdaqGS ˙ US28106W1036

Introduktion

Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Akshay Vaishnaw. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.

Genomsnittlig handelslönsamhet

Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.

Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.

Uppdateringsfrekvens: Dagligen

Se listan över mest lönsamma insiderhandlare

Se högst rankade insiders

Företag med rapporterade insiderpositioner

SEC-anmälningarna visar att Akshay Vaishnaw har rapporterat innehav eller affärer i följande företag:

Värdepapper	Titel	Senaste rapporterade innehav
US:SRRK / Scholar Rock Holding Corporation	President of R&D, Director	616 205
US:ALNY / Alnylam Pharmaceuticals, Inc.	President	22 774
US:EDIT / Editas Medicine, Inc.	Director	11 538

Hur man tolkar diagrammen

Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Akshay Vaishnaw. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.

I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.

Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.

Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.

Insiderköp EDIT / Editas Medicine, Inc. - Analys av kortsiktig vinst

I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i EDIT / Editas Medicine, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.

Handelsdatum	Ticker	Insider	Rapporterade aktier	Rapporterad pris	Justerade aktier	Justerat pris	Kostnadsgrund	Dagar till max	Pris vid max	Max vinst ($)	Maximal avkastning (%)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

EDIT / Editas Medicine, Inc. Insider Trades

Insiderförsäljning - Analys av kortsiktig förlust

I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i EDIT / Editas Medicine, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.

Handelsdatum	Ticker	Insider	Rapporterade aktier	Rapporterad pris	Justerade aktier	Justerat pris	Kostnadsgrund	Dagar till min	Pris vid min	Maximal förlust undvikits ($)	Maximal förlust undvikits ($)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

Insiderköp SRRK / Scholar Rock Holding Corporation - Analys av kortsiktig vinst

Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.

Handelsdatum	Ticker	Insider	Rapporterade aktier	Rapporterad pris	Justerade aktier	Justerat pris	Kostnadsgrund	Dagar till max	Pris vid max	Max vinst ($)	Maximal avkastning (%)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

SRRK / Scholar Rock Holding Corporation Insider Trades

Insiderförsäljning - Analys av kortsiktig förlust

Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.

Handelsdatum	Ticker	Insider	Rapporterade aktier	Rapporterad pris	Justerade aktier	Justerat pris	Kostnadsgrund	Dagar till min	Pris vid min	Maximal förlust undvikits ($)	Maximal förlust undvikits ($)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

Insiderhandelshistorik

Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Akshay Vaishnaw som avslöjats för Securities Exchange Commission (SEC).

Fildatum	Transaktionsdatum	Schema	Ticker	Värdepapper	Kode	10b5-1	Aktier	Återstående aktier	Procentuell förandring	Aktie pris	Transaktionsvärde	Återstående värde
2025-05-30	2025-05-29	4	SRRK	Scholar Rock Holding Corp Common Stock	S - Sale	X	−1 620	616 205	−0,26	30,01	−48 612	18 490 587
2025-05-30	2025-05-29	4	SRRK	Scholar Rock Holding Corp Common Stock	S - Sale	X	−5 130	617 825	−0,82	29,63	−152 000	18 305 969
2025-04-29	2025-04-27	4	SRRK	Scholar Rock Holding Corp Common Stock	A - Award		500 000	622 955	406,65
2025-04-29	2025-04-27	4	SRRK	Scholar Rock Holding Corp Common Stock	A - Award		100 000	122 955	435,63
2024-07-01	2024-06-27	4	SRRK	Scholar Rock Holding Corp Common Stock	A - Award		13 500	22 955	142,78
2023-08-07	2023-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−192	22 774	−0,84	189,31	−36 348	4 311 346
2023-08-07	2023-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−17	22 966	−0,07	188,40	−3 203	4 326 794
2023-08-07	2023-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−101	22 983	−0,44	187,37	−18 924	4 306 325
2023-08-07	2023-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−1 107	23 084	−4,58	186,39	−206 334	4 302 627
2023-08-07	2023-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−1 869	24 191	−7,17	185,54	−346 774	4 488 398
2023-08-07	2023-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−771	26 060	−2,87	184,70	−142 404	4 813 282
2023-08-07	2023-08-03	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		3 859	26 831	16,80
2023-08-07	2023-08-03	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		5 082	22 972	28,41
2023-04-28	2023-04-27	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−168	17 890	−0,93	197,08	−33 109	3 525 761
2023-04-28	2023-04-27	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−104	18 058	−0,57	195,65	−20 348	3 533 048
2023-04-28	2023-04-27	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−1 013	18 162	−5,28	194,94	−197 474	3 540 500
2023-04-28	2023-04-27	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−910	19 175	−4,53	193,93	−176 476	3 718 608
2023-04-28	2023-04-27	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale		−197	20 085	−0,97	193,18	−38 056	3 880 020
2023-04-28	2023-04-26	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		5 312	20 282	35,48
2023-02-14	2023-02-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−4 302	14 970	−22,32	217,05	−933 749	3 249 238
2023-02-14	2023-02-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−19 447	19 272	−50,23	216,38	−4 207 942	4 170 075
2023-02-14	2023-02-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−10 279	38 719	−20,98	215,59	−2 216 050	8 347 429
2023-02-14	2023-02-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−2 307	48 998	−4,50	214,28	−494 344	10 499 291
2023-02-14	2023-02-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 709	51 305	−3,22	213,13	−364 239	10 934 635
2023-02-14	2023-02-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	30 913	53 014	139,87	63,00	1 947 519	3 339 882
2022-12-07	2022-12-05	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−1 324	22 101	−5,65	226,20	−299 489	4 999 246
2022-12-07	2022-12-05	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		2 368	23 425	11,25	42,22	99 977	989 004
2022-12-07	2022-12-05	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		1 587	21 057	8,15	63,00	99 981	1 326 591
2022-12-07	2022-12-05	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		1 124	19 470	6,13	88,95	99 980	1 731 856
2022-08-05	2022-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−198	18 346	−1,07	210,75	−41 728	3 866 420
2022-08-05	2022-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−180	18 544	−0,96	210,66	−37 919	3 906 479
2022-08-05	2022-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−195	18 724	−1,03	210,22	−40 993	3 936 159
2022-08-05	2022-08-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−5 479	18 919	−22,46	189,76	−1 039 695	3 590 069
2022-08-05	2022-08-03	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		3 859	24 398	18,79
2022-08-05	2022-08-03	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		4 241	20 539	26,02
2022-08-05	2022-08-03	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		5 083	16 298	45,32
2022-05-27	2022-05-26	4	SRRK	Scholar Rock Holding Corp Stock Option (Right to Buy)	A - Award		28 000	28 000
2022-02-25	2022-02-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		29 842	29 842
2022-01-04	2021-12-31	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		22 380	22 380
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−303	11 215	−2,63	195,11	−59 118	2 188 159
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−145	11 518	−1,24	193,67	−28 082	2 230 691
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−126	11 663	−1,07	193,37	−24 365	2 255 274
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−73	11 789	−0,62	192,25	−14 034	2 266 435
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 000	11 862	−7,77	191,45	−191 450	2 270 980
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−125	12 862	−0,96	190,86	−23 858	2 454 841
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−142	12 987	−1,08	190,39	−27 035	2 472 595
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−73	13 129	−0,55	190,33	−13 894	2 498 843
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−5	13 202	−0,04	190,27	−951	2 511 945
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−144	13 207	−1,08	190,02	−27 363	2 509 594
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−144	13 351	−1,07	189,24	−27 251	2 526 543
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−8	13 495	−0,06	189,18	−1 513	2 552 984
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−73	13 503	−0,54	189,01	−13 798	2 552 202
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−127	13 576	−0,93	188,26	−23 909	2 555 818
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−130	13 703	−0,94	187,35	−24 356	2 567 257
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−137	13 833	−0,98	187,08	−25 630	2 587 878
2021-12-23	2021-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−124	13 970	−0,88	186,22	−23 091	2 601 493
2021-12-23	2021-12-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−122	14 094	−0,86	186,48	−22 751	2 628 249
2021-12-23	2021-12-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−1	14 216	−0,01	190,50	−190	2 708 148
2021-12-23	2021-12-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−2 415	14 217	−14,52	189,13	−456 749	2 688 861
2021-12-23	2021-12-21	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		5 417	16 632	48,30
2021-08-11	2021-08-09	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2013 (right to buy)	M - Exercise	X	−10 834	10 832	−50,00
2021-08-11	2021-08-09	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−10 834	11 215	−49,14	200,00	−2 166 800	2 243 000
2021-08-11	2021-08-09	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	10 834	22 049	96,60	63,00	682 542	1 389 087
2021-06-22	2021-06-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−970	2 368	−29,06
2021-06-22	2021-06-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2013 (right to buy)	M - Exercise	X	−10 834	21 666	−33,34
2021-06-22	2021-06-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−14 708	11 215	−56,74	175,00	−2 573 900	1 962 625
2021-06-22	2021-06-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	970	25 923	3,89	42,22	40 953	1 094 469
2021-06-22	2021-06-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	10 834	24 953	76,73	63,00	682 542	1 572 039
2021-06-07	2021-06-03	4	EDIT	Editas Medicine, Inc. Stock Option (right to buy)	A - Award		11 538	11 538
2021-06-01	2021-05-27	4	SRRK	Scholar Rock Holding Corp Stock Option (Right to Buy)	A - Award		7 800	7 800
2021-04-21	2021-04-21	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−107	14 119	−0,75	138,48	−14 817	1 955 199
2021-04-21	2021-04-21	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−530	14 226	−3,59	137,60	−72 928	1 957 498
2021-04-21	2021-04-21	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 892	14 756	−11,36	136,84	−258 901	2 019 211
2021-04-21	2021-04-21	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−203	16 648	−1,20	135,41	−27 488	2 254 306
2021-04-21	2021-04-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−85	16 851	−0,50	134,56	−11 438	2 267 528
2021-04-21	2021-04-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−2 266	16 936	−11,80	131,75	−298 546	2 231 318
2021-04-21	2021-04-19	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−417	19 202	−2,13	140,02	−58 388	2 688 664
2021-04-21	2021-04-19	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−622	19 619	−3,07	138,64	−86 234	2 719 978
2021-04-21	2021-04-19	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−989	20 241	−4,66	137,60	−136 086	2 785 162
2021-04-21	2021-04-19	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 678	21 230	−7,32	136,76	−229 483	2 903 415
2021-04-21	2021-04-19	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		5 083	22 908	28,52
2021-02-26	2021-02-24	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		28 800	28 800
2021-02-16	2021-02-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−92	17 825	−0,51	152,53	−14 033	2 718 847
2021-02-16	2021-02-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−1 618	17 917	−8,28	156,00	−252 408	2 795 052
2021-02-16	2021-02-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2017 (right to buy)	A - Award		8 334	25 000	50,01
2021-02-16	2021-02-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		5 416	19 535	38,36
2020-10-01	2020-09-29	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−971	3 338	−22,53
2020-10-01	2020-09-29	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−971	14 119	−6,43	140,00	−135 940	1 976 660
2020-10-01	2020-09-29	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	971	15 090	6,88	42,22	40 996	637 100
2020-06-24	2020-06-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−970	4 309	−18,37
2020-06-24	2020-06-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−195	14 119	−1,36	152,97	−29 829	2 159 783
2020-06-24	2020-06-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−334	14 314	−2,28	152,22	−50 841	2 178 877
2020-06-24	2020-06-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−180	14 648	−1,21	150,34	−27 061	2 202 180
2020-06-24	2020-06-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−83	14 828	−0,56	149,09	−12 374	2 210 707
2020-06-24	2020-06-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−178	14 911	−1,18	148,48	−26 429	2 213 985
2020-06-24	2020-06-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	970	15 089	6,87	42,22	40 953	637 058
2020-06-18	2020-06-16	4	SRRK	Scholar Rock Holding Corp Stock Option (right to buy)	A - Award		13 000	13 000
2020-06-12	2020-06-10	4	EDIT	Editas Medicine, Inc. Stock Option (right to buy)	A - Award		11 538	11 538
2020-04-22	2020-04-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−971	5 279	−15,54
2020-04-22	2020-04-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2016 (right to buy)	M - Exercise	X	−21 000	0	−100,00
2020-04-22	2020-04-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−21 971	14 119	−60,88	140,00	−3 075 940	1 976 660
2020-04-22	2020-04-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	971	36 090	2,76	42,22	40 996	1 523 720
2020-04-22	2020-04-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	21 000	35 119	148,74	42,22	886 620	1 482 724
2020-04-09	2020-04-07	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−98	14 119	−0,69	106,52	−10 439	1 503 956
2020-04-09	2020-04-07	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−2 415	14 217	−14,52	104,75	−252 971	1 489 231
2020-04-09	2020-04-07	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		5 417	16 632	48,30
2020-02-28	2020-02-26	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		27 623	27 623
2020-02-11	2020-02-07	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−18 750	6 250	−75,00
2020-02-11	2020-02-07	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2016 (right to buy)	M - Exercise	X	−4 000	21 000	−16,00
2020-02-11	2020-02-07	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−23 708	11 215	−67,89	125,00	−2 963 500	1 401 875
2020-02-11	2020-02-07	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	4 000	34 923	12,94	42,22	168 880	1 474 449
2020-02-11	2020-02-07	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	18 750	30 923	154,03	42,22	791 625	1 305 569
2019-12-26	2019-12-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2017 (right to buy)	A - Award		8 333	16 666	100,00
2019-11-26	2019-11-22	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2017 (right to buy)	A - Award		8 333	8 333
2019-08-07	2019-08-06	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2016 (right to buy)	A - Award		6 250	25 000	33,33
2019-08-07	2019-08-06	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2015 (right to buy)	A - Award		7 500	30 000	33,33
2019-08-07	2019-07-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	J - Other		48	515	10,28
2019-06-14	2019-06-12	4	EDIT	Editas Medicine, Inc. Stock Option (right to buy)	A - Award		11 538	11 538
2019-06-07	2019-06-05	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2016 (right to buy)	A - Award		6 250	18 750	50,00
2019-06-07	2019-04-09	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	J - Other		51	467	12,26
2019-06-07	2018-10-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	J - Other		21	416	5,32
2019-05-23	2019-05-21	4	SRRK	Scholar Rock Holding Corp Stock Option (Right to Buy)	A - Award		20 316	20 316
2019-03-01	2019-02-28	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		32 500	32 500
2018-09-28	2018-09-27	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2016 (right to buy)	A - Award		6 250	12 500	100,00
2018-09-28	2018-09-27	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2015 (right to buy)	A - Award		7 500	22 500	50,00
2018-08-23	2018-08-21	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2015 (right to buy)	A - Award		7 500	15 000	100,00
2018-08-14	2018-08-13	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−766	12 173	−5,92	90,95	−69 668	1 107 134
2018-08-14	2018-08-13	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		1 724	12 939	15,37
2018-08-14	2018-08-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Based Stock Option 2014 (right to buy)	A - Award		11 707	35 125	49,99
2018-08-14	2018-08-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Based Stock Option 2013 (right to buy)	A - Award		10 832	32 500	49,99
2018-08-14	2018-07-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	J - Other		29	395	7,92
2018-08-14	2018-04-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	J - Other		28	366	8,28
2018-06-19	2018-06-15	4	EDIT	Editas Medicine, Inc. Stock Option (right to buy)	A - Award		11 538	11 538
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−44 641	0	−100,00
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−38 913	0	−100,00
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−5 000	0	−100,00
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−6 380	11 215	−36,26	145,27	−926 823	1 629 203
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−20 172	17 595	−53,41	144,53	−2 915 459	2 543 005
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−19 213	37 767	−33,72	143,46	−2 756 297	5 418 054
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−21 336	56 980	−27,24	142,57	−3 041 874	8 123 639
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−15 000	78 316	−16,07	141,69	−2 125 350	11 096 594
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−6 453	93 316	−6,47	140,45	−906 324	13 106 232
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	5 000	99 769	5,28	7,10	35 500	708 360
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	38 913	94 769	69,67	16,43	639 341	1 557 055
2018-03-16	2018-03-14	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	44 641	55 856	398,05	18,66	833 001	1 042 273
2018-03-05	2018-03-01	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		25 000	25 000
2017-12-21	2017-12-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Based Stock Option 2016 (right to buy)	A - Award		6 250	6 250
2017-12-21	2017-12-19	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	G - Gift		−320	11 215	−2,77
2017-11-08	2017-11-06	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2015 (right to buy)	A - Award		7 500	7 500
2017-11-01	2017-10-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−33 666	0	−100,00
2017-11-01	2017-10-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−3 693	11 535	−24,25	122,79	−453 463	1 416 383
2017-11-01	2017-10-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−17 755	15 228	−53,83	121,69	−2 160 606	1 853 095
2017-11-01	2017-10-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−11 418	32 983	−25,72	120,78	−1 379 066	3 983 687
2017-11-01	2017-10-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−800	44 401	−1,77	119,79	−95 832	5 318 796
2017-11-01	2017-10-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	33 666	45 201	291,86	21,35	718 769	965 041
2017-09-22	2017-09-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2013 (right to buy)	A - Award		10 834	10 834
2017-07-11	2017-07-07	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2014 (right to buy)	A - Award		11 709	23 418	100,00
2017-06-19	2017-06-15	4	EDIT	Editas Medicine, Inc. Stock Option (right to buy)	A - Award		11 538	11 538
2017-06-15	2017-06-13	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise		−328	33 666	−0,96
2017-06-15	2017-06-13	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise		−1 340	44 641	−2,91
2017-06-15	2017-06-13	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−430	11 535	−3,59	74,31	−31 953	857 166
2017-06-15	2017-06-13	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		1 340	11 965	12,61	18,66	25 004	223 267
2017-06-15	2017-06-13	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		328	10 625	3,19	21,35	7 003	226 844
2017-05-25	2017-05-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−11 000	33 994	−24,45
2017-05-25	2017-05-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−11 000	10 297	−51,65	75,00	−825 000	772 275
2017-05-25	2017-05-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	11 000	21 297	106,83	21,35	234 850	454 691
2017-05-17	2017-05-15	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−32 750	0	−100,00
2017-05-17	2017-05-15	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−11 000	44 994	−19,64
2017-05-17	2017-05-15	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−11 000	10 297	−51,65	65,00	−715 000	669 305
2017-05-17	2017-05-15	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	11 000	21 297	106,83	21,35	234 850	454 691
2017-05-17	2017-05-15	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−32 750	10 297	−76,08	65,00	−2 128 750	669 305
2017-05-17	2017-05-15	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	32 750	43 047	318,05	31,39	1 028 022	1 351 245
2017-01-04	2016-12-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise		−4 356	55 994	−7,22
2017-01-04	2016-12-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise		−4 019	45 981	−8,04
2017-01-04	2016-12-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise		−1 172	38 913	−2,92
2017-01-04	2016-12-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−5 000	10 297	−32,69	37,44	−187 200	385 520
2017-01-04	2016-12-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		4 356	15 297	39,81	21,35	93 001	326 591
2017-01-04	2016-12-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		4 019	10 941	58,06	18,66	74 995	204 159
2017-01-04	2016-12-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		1 172	6 922	20,38	16,43	19 256	113 728
2016-12-22	2016-12-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		25 000	25 000
2016-12-02	2016-11-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−29 165	0	−100,00
2016-12-02	2016-11-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 500	5 750	−20,69	46,14	−69 208	265 298
2016-12-02	2016-11-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−13 297	7 250	−64,72	45,55	−605 662	330 229
2016-12-02	2016-11-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−14 368	20 547	−41,15	44,34	−637 127	911 126
2016-12-02	2016-11-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	29 165	34 915	507,22	22,75	663 504	794 316
2016-07-29	2016-07-28	4	EDIT	Editas Medicine, Inc. Stock Option (right to buy)	A - Award		23 076	23 076
2016-07-29		3	EDIT	Editas Medicine, Inc. No securities are beneficially owned				0
2016-02-25	2016-02-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		10 000	10 000
2016-02-03	2016-02-01	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance Stock Option 2014 (right to buy)	A - Award		11 709	11 709
2015-12-22	2015-12-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		30 000	30 000
2015-11-30	2015-11-25	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise		−835	29 165	−2,78
2015-11-30	2015-11-25	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise		−4 915	40 085	−10,92
2015-11-30	2015-11-25	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		4 915	5 750	588,62	16,43	80 753	94 472
2015-11-30	2015-11-25	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise		835	835		22,75	18 996	18 996
2015-06-18	2015-06-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−6 250	0	−100,00
2015-06-18	2015-06-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−2 500	5 000	−33,33
2015-06-18	2015-06-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−350	0	−100,00	131,00	−45 850
2015-06-18	2015-06-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 800	350	−83,72	130,06	−234 100	45 519
2015-06-18	2015-06-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−2 667	2 150	−55,37	128,79	−343 479	276 895
2015-06-18	2015-06-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−3 933	4 817	−44,95	128,10	−503 811	617 050
2015-06-18	2015-06-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	2 500	8 750	40,00	7,10	17 750	62 125
2015-06-18	2015-06-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 250	6 250		9,30	58 125	58 125
2015-05-05	2015-05-01	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	A - Award		35 125	35 125
2015-03-19	2015-03-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−6 250	6 250	−50,00
2015-03-19	2015-03-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−2 500	7 500	−25,00
2015-03-19	2015-03-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−644	0	−100,00	119,38	−76 881
2015-03-19	2015-03-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 000	644	−60,83	118,16	−118 160	76 095
2015-03-19	2015-03-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−2 080	1 644	−55,85	117,35	−244 088	192 923
2015-03-19	2015-03-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−3 802	3 724	−50,52	116,34	−442 325	433 250
2015-03-19	2015-03-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 224	7 526	−13,99	115,29	−141 115	867 673
2015-03-19	2015-03-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	2 500	8 750	40,00	7,10	17 750	62 125
2015-03-19	2015-03-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 250	6 250		9,30	58 125	58 125
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−6 251	12 500	−33,34
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−1 875	0	−100,00
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−2 500	10 000	−20,00
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−100	0	−100,00	95,00	−9 500
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−5 090	100	−98,07	94,40	−480 514	9 440
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−2 936	5 190	−36,13	93,42	−274 273	484 836
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 900	8 126	−18,95	92,33	−175 420	750 244
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−600	10 026	−5,65	91,47	−54 880	917 045
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	2 500	10 626	30,77	7,10	17 750	75 445
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 251	8 126	333,39	9,30	58 134	75 572
2014-12-16	2014-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	1 875	1 875		9,14	17 138	17 138
2014-12-16	2014-12-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Performance-Based Stock Option (Right to Buy)	A - Award		10 834	10 834
2014-09-17	2014-09-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−6 250	18 751	−25,00
2014-09-17	2014-09-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−1 875	1 875	−50,00
2014-09-17	2014-09-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−2 500	12 500	−16,67
2014-09-17	2014-09-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−800	0	−100,00	73,03	−58 422
2014-09-17	2014-09-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−6 625	800	−89,23	72,27	−478 766	57 813
2014-09-17	2014-09-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−3 200	7 425	−30,12	71,34	−228 275	529 669
2014-09-17	2014-09-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	2 500	10 625	30,77	7,10	17 750	75 438
2014-09-17	2014-09-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 250	8 125	333,33	9,30	58 125	75 562
2014-09-17	2014-09-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	1 875	1 875		9,14	17 138	17 138
2014-06-19	2014-06-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−6 250	25 001	−20,00
2014-06-19	2014-06-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−1 875	3 750	−33,33
2014-06-19	2014-06-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−2 500	15 000	−14,29
2014-06-19	2014-06-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−8 127	0	−100,00	69,97	−568 620
2014-06-19	2014-06-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−2 498	8 127	−23,51	69,33	−173 178	563 418
2014-06-19	2014-06-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 250	10 625	142,86	9,30	58 125	98 812
2014-06-19	2014-06-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	2 500	4 375	133,33	7,10	17 750	31 062
2014-06-19	2014-06-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	1 875	1 875		9,14	17 138	17 138
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−22 145	0	−100,00
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−6 249	31 251	−16,66
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−1 875	5 625	−25,00
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−2 500	17 500	−12,50
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 944	0	−100,00	75,15	−146 094
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−22 044	1 944	−91,90	74,08	−1 633 110	144 019
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−8 781	23 988	−26,80	73,34	−644 020	1 759 337
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	2 500	32 769	8,26	7,10	17 750	232 660
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 249	30 269	26,02	9,30	58 116	281 502
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	1 875	24 020	8,47	9,14	17 138	219 543
2014-03-20	2014-03-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	22 145	22 145		12,96	286 999	286 999
2014-02-25	2014-02-21	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	I - Other		−2 615	0	−100,00	90,10	−235 612
2014-01-27	2014-01-24	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−700	0	−100,00	87,44	−61 208
2014-01-27	2014-01-24	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 100	700	−61,11	86,60	−95 260	60 620
2014-01-27	2014-01-24	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−4 221	1 800	−70,10	85,77	−362 056	154 395
2014-01-27	2014-01-24	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 869	6 021	−23,69	84,57	−158 065	509 207
2014-01-27	2014-01-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	F - Taxes		−4 698	7 890	−37,32	89,49	−420 424	706 076
2013-12-18	2013-12-18	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		32 500	32 500
2013-12-18	2013-12-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−18 480	22 145	−45,49
2013-12-18	2013-12-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−9 980	12 588	−44,22	61,40	−612 762	772 891
2013-12-18	2013-12-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−8 500	22 568	−27,36	60,59	−514 999	1 367 352
2013-12-18	2013-12-17	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	18 480	31 068	146,81	12,96	239 501	402 641
2013-12-18	2013-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−6 250	37 500	−14,29
2013-12-18	2013-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−3 750	7 500	−33,33
2013-12-18	2013-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−5 000	20 000	−20,00
2013-12-18	2013-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−4 256	12 588	−25,27	60,78	−258 669	765 068
2013-12-18	2013-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−10 744	16 844	−38,94	60,19	−646 629	1 013 758
2013-12-18	2013-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	5 000	27 588	22,14	7,10	35 500	195 875
2013-12-18	2013-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 250	22 588	38,25	9,30	58 125	210 068
2013-12-18	2013-12-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	3 750	16 338	29,79	9,14	34 275	149 329
2013-09-12	2013-09-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−6 250	43 750	−12,50
2013-09-12	2013-09-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−700	12 588	−5,27	58,18	−40 724	732 333
2013-09-12	2013-09-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−5 550	13 288	−29,46	57,39	−318 514	762 598
2013-09-12	2013-09-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 250	18 838	49,65	9,30	58 125	175 193
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−6 250	50 000	−11,11
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−3 750	11 250	−25,00
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−5 000	25 000	−16,67
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−100	12 588	−0,79	31,75	−3 175	399 669
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−4 900	12 688	−27,86	31,07	−152 249	394 233
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	5 000	17 588	39,72	7,10	35 500	124 875
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−6 250	12 588	−33,18	31,07	−194 196	391 126
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 250	18 838	49,65	9,30	58 125	175 193
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−3 750	12 588	−22,95	31,07	−116 517	391 126
2013-06-13	2013-06-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	3 750	16 338	29,79	9,14	34 275	149 329
2013-03-11	2013-03-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	M - Exercise	X	−6 250	56 250	−10,00
2013-03-11	2013-03-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−6 250	12 588	−33,18	24,55	−153 415	308 990
2013-03-11	2013-03-11	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 250	18 838	49,65	9,30	58 125	175 193
2012-12-21	2012-12-20	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (right to buy)	A - Award		50 000	50 000
2012-12-12	2012-12-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−3 750	15 000	−20,00
2012-12-12	2012-12-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−6 250	62 500	−9,09
2012-12-12	2012-12-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−10 000	12 588	−44,27	19,00	−190 000	239 172
2012-12-12	2012-12-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	3 750	22 588	19,91	9,14	34 275	206 454
2012-12-12	2012-12-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	6 250	18 838	49,65	9,30	58 125	175 193
2012-12-12	2012-12-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−4 777	30 000	−13,74
2012-12-12	2012-12-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−4 777	12 588	−27,51	17,00	−81 209	213 996
2012-12-12	2012-12-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	4 777	17 365	37,95	7,10	33 917	123 292
2012-12-06	2012-12-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−2 400	34 777	−6,46
2012-12-06	2012-12-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−2 400	12 588	−16,01	17,04	−40 896	214 500
2012-12-06	2012-12-04	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	2 400	14 988	19,07	7,10	17 040	106 415
2012-12-04	2012-11-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−2 823	37 177	−7,06
2012-12-04	2012-11-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−2 823	12 588	−18,32	17,03	−48 072	214 359
2012-12-04	2012-11-30	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	2 823	15 411	22,43	7,10	20 043	109 418
2012-09-12	2012-09-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−4 916	68 750	−6,67
2012-09-12	2012-09-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−4 916	12 588	−28,09	19,00	−93 404	239 172
2012-09-12	2012-09-12	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	4 916	17 504	39,05	9,30	45 719	162 787
2012-09-12	2012-09-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−1 334	73 666	−1,78
2012-09-12	2012-09-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−1 334	12 588	−9,58	19,00	−25 346	239 172
2012-09-12	2012-09-10	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	1 334	13 922	10,60	9,30	12 406	129 475
2012-07-18	2012-07-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−25 000	75 000	−25,00
2012-07-18	2012-07-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Stock Option (Right to Buy)	M - Exercise	X	−11 250	18 750	−37,50
2012-07-18	2012-07-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−11 250	12 588	−47,19	19,00	−213 750	239 172
2012-07-18	2012-07-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	11 250	23 838	89,37	9,14	102 825	217 879
2012-07-18	2012-07-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	S - Sale	X	−25 000	12 588	−66,51	19,00	−475 000	239 172
2012-07-18	2012-07-16	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	M - Exercise	X	25 000	37 588	198,60	9,30	232 500	349 568
2012-01-25	2012-01-23	4	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock	A - Award		12 588	12 588
2009-03-13		3	ALNY	ALNYLAM PHARMACEUTICALS, INC. Common Stock				799

Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet

Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet

Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)

Omvandling av derivat

Försäljning eller överföring av värdepapper tillbaka til företaget

Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget

Överlåtelse av värdepapper från eller till insidern

Aktieswappar och liknande säkringsaffärer

Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)

En transaktion friviligt rapporterad på schema 4

Andra (med en fotnot som beskriver transaktionen)